EDUCATION:
| B.S. |
|
Biology,
University of Dayton, Dayton, Ohio |
|
EXPERIENCE:
|
CURRENT
POSITION
(Jun. 2007 - present) |
|
Head,
North Carolina Office, Biologics Consulting Group
Inc.
Cary, NC. |
|
|
|
| Jan.
2002 - May 2007 |
|
VP,
Regulatory Affairs/Quality Assurance, Biolex
Pittsboro, NC.
- Managed
the Regulatory affairs, Quality Assurance and Quality
control functions for Biolex.
- Assure
compliance with applicable federal, local and international
regulations.
- Develop
regulatory strategies for the development of biopharmaceuticals
- Conducted
Pre-IND meetings with the FDA and EU authorities
- Establish
and maintain quality systems.
- Provide
QA and QC support for the establishment of a GMP clinical
supply manufacturing operation
- Interact
with CROs in conducting preclinical studies and IND
preparation
- Represent
Biolex in interactions with regulatory agencies, and
industry organizations.
- Represent
Biolex QA/QC/RA in interactions with US and international
partners and in due diligence activities
- Successful
filings of an IND and CTAs for alpha interferon Phase
1 and Phase 2 clinical trials
|
|
|
|
| Oct.
2000 - Dec. 2001 |
|
Vice
President of Quality Systems, Xanthon
Research Triangle Park, NC.
- Responsible
for establishing The Quality Systems for Xanthon in
compliance with the Quality System Regulations and
establishing the QA/QC functions.
|
|
|
|
| Mar.
1996 - Oct. 2000 |
|
Associate
Director of Quality, Biogen
Research Triangle Park, NC.
- Responsible
for the overall management of the Quality Assurance
and Quality Control operations for Biogen's RTP bulk
Avonex manufacturing site including QA Compliance,
Documentation, QA Chemistry, QA Biology, Bioassay
and Virology.
- Directed
QA, QC and CMC activities for BLA submission and licensure
of the Biogen RTP Avonex manufacturing facility
- Established
the QA/QC functions for the start up of the manufacturing
site and guided the facility to successful preapproval
inspections by the FDA, EMEA, Canadian and Russian
authorities achieving FDA licensure within 33 months
form the initiation of construction.
- Responsible
for review and approval of all validation protocols
- Primary
contact for FDA and other regulatory agencies including
a successful Team Biologics inspection.
|
|
|
|
| 1991
- 1996 |
|
Director
of Quality Assurance, Pharmacia
Clayton, NC.
- Responsible
for overall management of the Quality Assurance and
Quality control functions for Pharmacia's US LVP and
lipid based drug delivery operations including QA
Inspection, Quality Engineering, QA Compliance, Documentation,
QA Biology and QA Chemistry.
|
|
|
|
| 1988
- 1991 |
|
Quality
Engineer, Pharmacia
Clayton, NC.
- Managed
QA Inspection and Quality Engineering functions.
- Established
internal audit program and supplier QA program
- Provided
technical support for validation activities and reviewed
and approved validation protocols
|
|
|
|
| 1985
- 1988 |
|
Quality
Control and Sterilization Manager, Becton Dickinson
(B-D Division)
Canaan, CT.
- Responsible
for management of the Quality Control and Sterilization
departments of a 600 employee Medical Device Manufacturing
facility.
- Responsibilities
included management and validation of EO, Cobalt and
E-beam sterilization processes, Technical Services,
Quality Improvement, QC Inspection and Microbiological
testing, environmental monitoring, validation of non-sterilization
processes.
- Primary
contact for FDA and NRC inspections
- Participated
in Juran Quality Improvement program
- Oversaw
the successful commissioning of the E-beam sterilization
operation
|
|
|
|
| 1982
- 1985 |
|
Chief
Microbiologist, Becton Dickinson (B-D Respiratory
Care)
Ocala, FL.
- Responsible
for management of the Microbiology and Sterilization
Departments including EO sterilization operations,
sterility testing, environmental monitoring, validation
of EO and aseptic filling operations.
|
|
|
|
| 1980
- 1982 |
|
Microbiology
Manager, C.R. Bard, Bard Urological Division
Covington, GA
- Responsible
for start-up and management of the Microbiology department
and EO sterilization validation.
|
|
|
|
| 1978
- 1980 |
|
Quality
Engineer, C.R. Bard, Bard Urological Division
Covington, GA.
- Responsible
for establishing incoming inspection, in-process and
finished goods inspection procedures and EO sterilization
validation
|
|
|
|
| 1976
- 1978 |
|
Microbiologist,
Becton Dickinson
Rutherford, NJ.
- Responsible
for sterility testing, environmental monitoring, E-beam
and EO sterilization validation
|
| ACCREDITATIONS |
- ASQ
Certified Quality Engineer and ASQ Certified Quality
Auditor
|
|
| PRESENTATIONS |
| 1) |
Aug
2005 Strategic Research Institute Third annual Generics
Biopharmaceuticals Global Summit - Enablement of Follow-on
Biologics Interferon alfa 2b From the LEX System |
| 2) |
Oct
2006 IQPC Risk Management in Pharmaceutical Manufacturing
- Risk Management and Regulatory Compliance in the Development
of a Novel Manufacturing Platform |
| 3) |
Jan
2007 IQPC Process Scale-up for Pharmaceutical and Biologics
Development - Incorporating GMP Compliance into Preclinical
and Clinical Development |
Page
Updated
June 16, 2008
|